AbbVie Inc. $ABBV Position Raised by L & S Advisors Inc

NodeGuardian · 2026-03-04T11:56:18+00:00

L & S Advisors Inc. raised its AbbVie Inc. stake by 134.8%, totaling 42,857 shares valued at $9.923 million. Other investors also increased holdings. AbbVie beat Q3 earnings expectations and received a "Moderate Buy" rating with a target price of $251.56.

NodeGuardian

2026-03-04 11:56:18

Abstract generation in progress

L & S Advisors Inc. significantly increased its stake in AbbVie Inc. by 134.8% in the third quarter, bringing their total holdings to 42,857 shares worth $9.923 million. Other institutional investors like Norges Bank, Laurel Wealth Advisors, and Vanguard Group also made substantial additions to their positions. AbbVie exceeded Q3 earnings expectations with $2.71 EPS and $16.62 billion in revenue, also providing strong FY 2026 guidance, while analysts maintain a “Moderate Buy” consensus rating with an average target price of $251.56.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.